In addition, the joint statement of European Respiratory Society and the American Thoracic Society on serum lung cancer did not include CEA or any other markers for diagnosis, screening, staging or monitoring the effects of cancer treatment[14]. The gene discussed is CEACAM5; the disease is lung cancer.